N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide
C266H387N43O36S3 — CID 160972571
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide
N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide (PubChem CID 160972571) has the molecular formula C266H387N43O36S3 and a molecular weight of 4859.49 g/mol. Its IUPAC name is N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide.
Molecular Properties
| Compound Name | N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide |
|---|---|
| PubChem CID | 160972571 |
| Molecular Formula | C266H387N43O36S3 |
| Molecular Weight | 4859.49 g/mol |
| Exact Mass | 4855.89 |
| IUPAC Name | N-(2-amino-2-oxoethyl)-2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methylacetamide;1-(cyclobutylmethyl)-3-[2-(1,1-dioxo-1,4-thiazinan-4-yl)-2-oxoethyl]-8-(methylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[[2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]acetyl]-methylamino]-2-methylpropanamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N,N-dimethyl-4-oxopentanamide;2-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-N-methyl-N-[2-(methylamino)-2-oxoethyl]acetamide;5-[1-(cyclobutylmethyl)-8-(methylamino)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(5-methylsulfonyl-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-[3-(6-methylsulfonyl-2-pyridinyl)-2-oxopropyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-1-[(1-hydroxycyclobutyl)methyl]-3-(2-oxo-3-pyrimidin-5-ylpropyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;2-[8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-1-yl]-N,N-dimethylacetamide |
| SMILES | CN(C)C(=O)CN1C(=O)N(CC(=O)CCCO)CC12CCC(c1ccccc1)(N(C)C)CC2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCCS(C)(=O)=O)C(=O)N2CC1(O)CCC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)Cc1cccc(S(C)(=O)=O)n1)C(=O)N2CC1(O)CCC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)Cc1cncnc1)C(=O)N2CC1(O)CCC1.CNC(=O)CN(C)C(=O)CN1CC2(CCC(NC)(c3ccccc3)CC2)N(CC2CCC2)C1=O.CNC1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCC(=O)N(C)C)C(=O)N2CC1CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCC(N)=O)C(=O)N2CC1CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(CC(=O)N(C)C(C)(C)C(N)=O)C(=O)N2CC1CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(CC(=O)N(C)CC(N)=O)C(=O)N2CC1CCC1.CNC1(c2ccccc2)CCC2(CC1)CN(CC(=O)N1CCS(=O)(=O)CC1)C(=O)N2CC1CCC1 |
| InChI | InChI=1S/C30H40N4O5S.C28H37N5O3.C27H41N5O3.C27H40N4O3.C27H41N3O5S.C26H39N5O3.C26H38N4O4S.C25H37N5O3.C25H38N4O4.C25H36N4O3/c1-32(2)30(23-9-5-4-6-10-23)17-15-28(16-18-30)21-33(27(36)34(28)22-29(37)13-8-14-29)20-25(35)19-24-11-7-12-26(31-24)40(3,38)39;1-31(2)28(23-7-4-3-5-8-23)13-11-26(12-14-28)19-32(18-24(34)15-22-16-29-21-30-17-22)25(35)33(26)20-27(36)9-6-10-27;1-25(2,23(28)34)30(4)22(33)18-31-19-26(32(24(31)35)17-20-9-8-10-20)13-15-27(29-3,16-14-26)21-11-6-5-7-12-21;1-28-27(22-10-5-4-6-11-22)16-14-26(15-17-27)20-30(19-23(32)12-13-24(33)29(2)3)25(34)31(26)18-21-8-7-9-21;1-28(2)27(22-9-5-4-6-10-22)16-14-25(15-17-27)20-29(19-23(31)11-7-18-36(3,34)35)24(32)30(25)21-26(33)12-8-13-26;1-27-22(32)17-29(3)23(33)18-30-19-25(31(24(30)34)16-20-8-7-9-20)12-14-26(28-2,15-13-25)21-10-5-4-6-11-21;1-27-26(22-8-3-2-4-9-22)12-10-25(11-13-26)20-29(24(32)30(25)18-21-6-5-7-21)19-23(31)28-14-16-35(33,34)17-15-28;1-27-25(20-9-4-3-5-10-20)13-11-24(12-14-25)18-29(17-22(32)28(2)16-21(26)31)23(33)30(24)15-19-7-6-8-19;1-26(2)22(32)18-29-23(33)28(17-21(31)11-8-16-30)19-24(29)12-14-25(15-13-24,27(3)4)20-9-6-5-7-10-20;1-27-25(20-8-3-2-4-9-20)14-12-24(13-15-25)18-28(17-21(30)10-11-22(26)31)23(32)29(24)16-19-6-5-7-19/h4-7,9-12,37H,8,13-22H2,1-3H3;3-5,7-8,16-17,21,36H,6,9-15,18-20H2,1-2H3;5-7,11-12,20,29H,8-10,13-19H2,1-4H3,(H2,28,34);4-6,10-11,21,28H,7-9,12-20H2,1-3H3;4-6,9-10,33H,7-8,11-21H2,1-3H3;4-6,10-11,20,28H,7-9,12-19H2,1-3H3,(H,27,32);2-4,8-9,21,27H,5-7,10-20H2,1H3;3-5,9-10,19,27H,6-8,11-18H2,1-2H3,(H2,26,31);5-7,9-10,30H,8,11-19H2,1-4H3;2-4,8-9,19,27H,5-7,10-18H2,1H3,(H2,26,31) |
| InChIKey | SYLJFEIVKIKNKX-UHFFFAOYSA-N |
| XLogP | 25.87 |
| TPSA | 925.30 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 49 |
| Rotatable Bonds | 84 |
| Heavy Atoms | 348 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4859.49 |
| LogP ≤ 5 | 25.87 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 49 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160972571 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.